Approximate cost of using pirfenidone for one month

Pirfenidone is a drug used to treat idiopathic pulmonary fibrosis (IPF). IPF is a progressive and fatal lung disease that is usually accompanied by a gradual decline in lung function, causing great trouble to patients' lives. Pirfenidone helps patients delay the disease and improve their quality of life by slowing the progression of pulmonary fibrosis. As the original drug pirfenidone has been approved for marketing in China and has been included in the Class B medical insurance catalog, patients can enjoy certain medical insurance reimbursement support during treatment. However, as pirfenidone is an innovative drug, the cost of treatment is relatively high, and the cost that patients need to pay is still a concern for many patients.

The common specifications of pirfenidone are100mg/tablet, 54 pills per box. The price on the market is about RMB 500 per box. If the patient takes the recommended dose of 200 mg three times a day, the number of medications required per month is approximately 60 pills, which means the patient needs to purchase approximately 1.5 boxes of medication. Based on this calculation, the cost of medication for a month is approximately RMB 750. However, patient-specific costs will be affected by individual treatment regimens and fluctuations in drug prices.

In China, pirfenidone has been included in the Category B list of medical insurance, which means that patients who meet the indications can enjoy partial reimbursement of drug costs according to local medical insurance policies. Usually, the reimbursement ratio for Class B drugs is 50%-70%, depending on the region where the patient is located and the medical insurance policy. If the medical insurance reimbursement ratio is 60%, the patient's monthly out-of-pocket expense will be approximately RMB 300-400, which greatly reduces the patient's financial burden.

However, since medical insurance policies and drug prices may differ in different regions, patients should understand the local reimbursement situation when using this drug. In addition, some patients may be able to further reduce the cost of treatment through drug assistance programs, hospital preferential policies, or discounts provided by drug companies.

Reference materials:https://www.esbriet.com/